28.8EGP
- Active ingredient
- raloxifene hydrochloride
- Strength
- 60 mg
- Form
- tablet
- Manufacturer
- pharopharma
- Route
- oral.solid
Uses
Indicated for treatment and prevention of osteoporosis in postmenopausal women and for reducing the risk of invasive breast cancer in selected postmenopausal women.
Do not use if
Active or previous venous thromboembolism and pregnancy.
Side effects
Common adverse effects include hot flashes, leg cramps, peripheral edema, arthralgia, and sweating.
Warnings
May increase the risk of venous thromboembolism and fatal stroke in certain patients.
How it works
Selective estrogen receptor modulator that acts as an estrogen agonist in some tissues and antagonist in others.
Storage
Store at controlled room temperature.